bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair
12 mars 2019 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
06 mars 2019 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
South Texas Veterans Health Care System Joins Test Validation Trial of bioAffinity’s CyPath® Lung
23 oct. 2018 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the South Texas Veterans Health Care System (STVHCS), which is...
Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung
18 sept. 2018 14h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
bioAffinity Technologies Welcomes Mohsin Y. Meghji to Board of Directors
31 juil. 2018 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 31, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Mohsin...
bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung
17 juil. 2018 14h40 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an...
bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
05 janv. 2018 09h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
bioAffinity Technologies Welcomes New Board Members
29 nov. 2017 11h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
bioAffinity Technologies Announces $4 Million Series A Funding
19 juil. 2017 15h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 19, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early-stage cancer diagnostics and precision therapeutics, announced today that it raised...
City of San Antonio Invests in bioAffinity Technologies
09 mars 2017 19h02 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...